1/1
Efficacy and Safety of Intravitreal Aflibercept Treat-And-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR
Version 3 2020-11-05, 11:50
Version 2 2020-11-04, 13:55
Version 1 2020-01-28, 09:07
figure
posted on 2020-11-05, 11:50 authored by Masahito Ohji, Kanji Takahashi, Annabelle A. Okada, Masato Kobayashi, Yoshimi Matsuda, Yasuhiro Terano, ALTAIR InvestigatorsArticle full text
The above summary slide, video abstract, script and storyboard represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
